Ichnos Glenmark Innovation at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Ichnos Glenmark Innovation brings 2 presentations to PEGS Europe 2026 in Lisbon. Its program centres on multispecific antibodies as immune engagers and the lessons from developing them. It also covers an end-to-end workflow for producing drug-like multispecific antibodies.

OrganizationPEGS Europe 2026 Attendance
iginnovate.com
Biotech
Develops multispecific antibodies for blood cancers and solid tumours using its BEAT platform.
Talk
Thu Nov 19
9:15am–9:30am
Lessons in the Development of Multispecific Antibodies as Immune Engagers
Engineering the Next Generation of Bispecific Antibodies
Talk
Thu Nov 19
3:35pm–4:05pm
An Integrated End-to-End Workflow for the Production of Drug-Like Multispecific Therapeutic Antibodies
Highly Parallel Protein Discovery Workflows

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ichnos Glenmark Innovation

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction